Instituto Mário Penna pays tribute to FIEMG in gratitude for the partnership in the construction of beds in Covid

Instituto Mário Penna is very proud of its partners and makes a point of recognizing who is present in its mission, helping with the treatment of patients and contributing to the institution’s structural and technological improvements. At this time of pandemic, the Federation of Industries of the State of Minas Gerais (FIEMG) spared no effort so that the institution could expand cancer care to also serve patients affected by Covid-19. To register this gratitude, a plaque was placed in the Espaço Benfeitoria Mário Penna – a wall with homage to donors and contributors who are part of the institution’s 50-year history.

This Monday, June 14, the president of FIEMG, Flávio Roscoe, was at Instituto Mário Penna to monitor the insertion of the plaque and the inauguration of the new CTI Covid facilities at Hospital Luxemburgo. In 2020, FIEMG donated R$ 4 million, which were invested in activating the José Rodrigo Machado Zica wing, at Hospital Mario Penna. This year, there were another R$ 866 thousand in CTI equipment.

Currently, the Instituto Mário Penna has 300 beds in total, 29 in the ICU and 60 in the infirmary. With this new FIEMG partnership, also involving other donors, it was possible to implement 9 more ICU beds and 20 in the infirmary.

“Since the beginning of the pandemic caused by Covid-19, the productive sector has been working to help mitigate its impacts on society. We understand that it was necessary to support the state’s health units, as we knew that there was not the necessary number of beds for the treatment of patients”, said Flávio Roscoe, president of FIEMG, thanking, on behalf of the entire industrial sector, the honor received. .

Also present and honored for supporting the Mário Penna Institute, Diego Andrade, Federal Deputy, Leader of the PSD National Bank, Majority Leader in the Federal Chamber and Active Member of the Parliamentary Front for Combating Cancer; Ciro Pereira, Councilor and President of the International Affairs Committee of the Municipality of Belo Horizonte; Laila Katina, Superintendent of Union Relations at FIEMG and Felipe Mota, Consul of Mexico.

Councilor Ciro Pereira thanked the opportunity to unite the two initiatives that made the beds viable. “When I looked for President Flávio Roscoe, he was ready to provide more structure to confront Covid, in which Mário Penna is the protagonist in the capital”. The councilor also spoke of the perspective of the Chamber approving amendments to the budgets to councilors and that he has already assumed that part of it will be allocated to the Institute.

“This partnership with FIEMG brings us even closer to society and our responsibilities as a philanthropic institution. We were only able to become one of the largest patient care hospitals with Covid because we had this important support. It is a very important moment in the history of Instituto Mário Penna and we just have to thank you for your trust and support in our work”; highlights Marco Antônio Viana Leite, CEO of Instituto Mário Penna.

Funed partners with Mario Penna to develop cancer research

The Ezequiel Dias Foundation (Funed), through its Molecular Biology Service (SBM), has just signed a partnership with the Mário Penna Institute, through the Teaching and Research Nucleus (NEP). The institution is philanthropic, a reference in cancer prevention, diagnosis, treatment, teaching and research in Minas Gerais.

The objective of the cooperation is to establish a partnership for research, development and innovation, through the Oncology Biomarkers Research Network. According to Luciana Maria Silva, Funed researcher responsible for the work, the partnership is strategic to provide advances in the understanding of the carcinogenesis of human tumors. “Oncology research can be of the basic or translational type, but together they can promote the health of patients diagnosed with the disease, with the objective of advancing important discoveries that go from the bench to the bedside “, claims.

Funed participates as an Institute of Science and Technology (ICT) whose purpose is to carry out research for scientific and technological development in the field of public health, in research and production of medicines, as well as in laboratory analyzes in the field of harm to collective health . The expectation is that the cooperation will provide advances in several researches, but particularly in the research that is underway on ovarian cancer. “This process can contribute to the development of new drugs, diagnostic kits and other products for human health”, exemplifies Luciana.

The Mário Penna Institute – named after the doctor who became a pioneer in cancer treatment in Minas Gerais – has reference hospitals in cancer treatment, such as Hospital Mário Penna and Hospital Luxemburgo, in addition to the Beatriz Ferraz Support House, which welcomes patients from the countryside undergoing treatment at the Institute’s hospitals, the Center for Oncology Specialties (NEO) and a Center for Teaching and Research to discover treatments, diagnoses and a better understanding of cancer.

Currently, Instituto Mário Penna is responsible for attending 70% of new cancer cases in Belo Horizonte and its metropolitan region, and more than 20% of new cancer cases in the entire State of Minas Gerais. Defined as a fundamental part of the Institute’s strategic planning, the research activity developed through its Teaching and Research Center involves a multidisciplinary professional body, including members of the clinical staff who work in the investigation and production of data, generating knowledge and advances in the field of oncology.

The Translational Research Laboratory of the IMP’s Teaching and Research Nucleus is headed by researcher Letícia da Conceição Braga, Luciana Silva’s research partner, and carried out her doctoral experiments at Funed’s SBM. The two researchers are responsible for bringing innovation in cancer biotechnology to Minas Gerais, through the creation of the startup OncoTag, which was born at the Foundation in 2014, and which has in its development portfolio a molecular test for patients with ovarian cancer. According to Luciana, the pair has experience, complicity and commitment so that the two institutions can help improve the treatment of cancer patients through their research.

Relevance – Cancer is the second leading cause of death worldwide. According to the World Health Organization (WHO), in 2018 there were 10 million deaths due to cancer in the world. “Cancer continues to grow globally, exerting tremendous physical, emotional and financial strain on people, families, communities and healthcare systems. Many of them, from middle-income countries like Brazil, are less prepared to manage this burden and many patients do not have access to adequate diagnosis and treatment”, recalls Luciana Silva.

Dr. Letícia Braga adds that this partnership with Funed means the joining of efforts of researchers and institutions working to strengthen the Unified Health System (SUS) can make a difference in this scenario and promote health through research and innovation for patients in the SUS.

 

ALMG allocates R$ 5 million from Vale’s repair agreement to Instituto Mário Penna

The Mário Penna Institute will receive R$ 5 million in funding from the Legislative Assembly of Minas Gerais (ALMG), resulting from the State’s agreement with Vale to repair damages resulting from the rupture of the Brumadinho dam. The announcement was made on the afternoon of Friday, August 13, at a ceremony in the plenary, under the command of the President of the House, Deputy Agostinho Patrus.

Marco Antônio Viana Leite speaks at ALMG

The CEO of Instituto Mário Penna, Marco Antônio Viana Leite, was present at the event and, during his speech, highlighted the importance of this resource. “We are a philanthropic institution and we need donations to serve our patients with quality and in a humane way. More than 260 thousand people visit our institution each year, coming from all corners of Minas Gerais. We serve more than 600 municipalities that refer their residents for cancer treatment at the Institute, including the cities affected by the Brumadinho disaster.
It is important to highlight that, after the dam collapsed, analyzes point to an increase in the records of cancer patients in these locations as a result of exposure to water contaminated by heavy metals. Therefore, this resource will be of great value at this time for the purchase of medicines and to provide improvements in patient care”.

Classified by the Ministry of Health as a High Complexity Oncology Care Center (CACON), in 2020 the Mário Penna Institute also carried out 272 thousand radiotherapy applications, 34 thousand chemotherapy sessions, 55 bone marrow transplants and almost 11 thousand surgeries. In addition, it is at the forefront in the fight against Covid-19 and, for this, infirmary beds and other new ICU beds were created, aimed at treating patients with the disease.

The donation – The donation made by ALMG totals R$ 84.5 million and covers social assistance programs, health institutions and support for the production process of the vaccine against Covid-19. In addition to the CEO of Instituto Mário Penna, Marco Antônio Viana Leite, representatives of other benefited entities also attended the ceremony such as the dean of UFMG, professor Sandra Regina Goulart Almeida, representatives of the Rede Cuidar Program, the Bolsa Reciclagem Program, of the Hospital da Baleia and the Intersectorial Committee for Monitoring and Monitoring the State Policy for the Homeless Population (PopRua-MG).

NEP celebrates National Science Day and Researcher’s Day

National Science Day and Researcher Day are celebrated on July 8th. The date was created to highlight the importance of science for the country’s development, stimulate the interest of young people and disseminate scientific knowledge to society. Instituto Mário Penna has a Teaching and Research Nucleus (NEP) composed of a team of researchers dedicated exclusively to the development of scientific projects and clinical research applied to oncology.

The NEP was founded in 2015 with the purpose of acting in the investigation and production of scientific data. “Over the years, we have been generating knowledge and advances in the field of oncology, based on basic, translational and clinical research”; explains Dr. Paulo Guilherme, pathologist and Director of the Teaching and Research Center.

In Basic and Translational Research, the projects under development aim to identify cancer markers capable of offering a better quality of life to cancer patients, as well as supporting medical decisions. The research results should allow for an increasingly personalized medicine for the treatment of cancer patients. Currently, two projects approved by the National Oncology Care Program (Pronon) and dedicated to the research of biomarkers in female cancers (cervical, breast and ovarian cancer) and to the implementation of the first tumor bank in the State of Minas Gerais are underway. In addition, five doctoral and seven master’s projects are being developed, supervised by NEP researchers, in partnership with UFMG, UFU, Funed and Fio Cruz.

In Clinical Research, IMP researchers are currently working on three open studies for patient/volunteer recruitment: the Thor study for the treatment of bladder cancer and the Rigel and Kiniksa studies for the treatment of inpatients due to complications of cancer. Covid.

“In the coming months, we expect to open four more studies focusing on Covid’s treatment and another four to offer treatment for lung, cervical and bladder cancer”; emphasizes Dr. Paulo Guilherme.

Instituto Galo makes donations to Mário Penna

On July 9, Instituto Galo and Auto Truck delivered 450 sweaters, 1,000 socks and 300 double blankets to Instituto Mário Penna. The action is part of the “Donate Protection” campaign, which aimed to collect cold items for the institution’s patients.

Marco Antônio Viana Leite, President of Instituto Mário Penna, received the delivery during a visit to the institute by the president of Clube Atlético Mineiro, Sérgio Coelho, the president of Instituto Galo, Maria Alice Melo Coelho, the CEO, Thiago Camargo and the former player Reinaldo.

They got to know the Mário Penna Memorial, recently launched in the 50th anniversary of Mário Penna, telling the history of the institution through the walls of the Hospital Luxemburgo. Then, they went to Espaço Benfeitoria, where they received plaques in honor of the important partnership.

Photo: Bruno Souza/Atlético

Along with the team’s mascot, Crazy Cock, the delegation circulated through the hospital’s facilities, talking to collaborators and chemotherapy patients.

“This partnership is extremely important for Mário Penna. We receive patients from all over Minas Gerais. And in this very cold moment, being able to donate warm clothes to those who come from so far away, it’s wonderful. It’s a comfort, a caress in a difficult time of treatment that makes all the difference. I have to thank Atlético Mineiro and Instituto Galo for their support that will provide us with a more welcoming and warm service to patients”; reinforces Marco Antônio Viana Leite.

Instituto Galo is a non-profit association, linked to Clube Atlético Mineiro, dedicated to transforming people’s lives through the love of Galo.

Olá, como podemos ajudar?

Damos valor à sua privacidade

Nós e os nossos parceiros armazenamos ou acedemos a informações dos dispositivos, tais como cookies, e processamos dados pessoais, tais como identificadores exclusivos e informações padrão enviadas pelos dispositivos, para as finalidades descritas abaixo. Poderá clicar para consentir o processamento por nossa parte e pela parte dos nossos parceiros para tais finalidades. Em alternativa, poderá clicar para recusar o consentimento, ou aceder a informações mais pormenorizadas e alterar as suas preferências antes de dar consentimento. As suas preferências serão aplicadas apenas a este website.

Cookies estritamente necessários

Estes cookies são necessários para que o website funcione e não podem ser desligados nos nossos sistemas. Normalmente, eles só são configurados em resposta a ações levadas a cabo por si e que correspondem a uma solicitação de serviços, tais como definir as suas preferências de privacidade, iniciar sessão ou preencher formulários. Pode configurar o seu navegador para bloquear ou alertá-lo(a) sobre esses cookies, mas algumas partes do website não funcionarão. Estes cookies não armazenam qualquer informação pessoal identificável.

Cookies de desempenho

Estes cookies permitem-nos contar visitas e fontes de tráfego, para que possamos medir e melhorar o desempenho do nosso website. Eles ajudam-nos a saber quais são as páginas mais e menos populares e a ver como os visitantes se movimentam pelo website. Todas as informações recolhidas por estes cookies são agregadas e, por conseguinte, anónimas. Se não permitir estes cookies, não saberemos quando visitou o nosso site.

Cookies de funcionalidade

Estes cookies permitem que o site forneça uma funcionalidade e personalização melhoradas. Podem ser estabelecidos por nós ou por fornecedores externos cujos serviços adicionámos às nossas páginas. Se não permitir estes cookies algumas destas funcionalidades, ou mesmo todas, podem não atuar corretamente.

Cookies de publicidade

Estes cookies podem ser estabelecidos através do nosso site pelos nossos parceiros de publicidade. Podem ser usados por essas empresas para construir um perfil sobre os seus interesses e mostrar-lhe anúncios relevantes em outros websites. Eles não armazenam diretamente informações pessoais, mas são baseados na identificação exclusiva do seu navegador e dispositivo de internet. Se não permitir estes cookies, terá menos publicidade direcionada.

Visite as nossas páginas de Políticas de privacidade e Termos e condições.

Importante: Este site faz uso de cookies que podem conter informações de rastreamento sobre os visitantes.